在已故捐赠者脏移植中使用红血球蛋白延迟移植功能的感染风险:研究信件
Mathew Kunthara1, Greg A Knoll2, David Massicotte-Azarniouch2
1Division of Nephrology, Department of Medicine, University of Ottawa, ON, Canada.
Canadian journal of kidney health and disease
|May 12, 2025
概括
在低风险脏移植接受者中,使用抗胸细胞球蛋白 (ATG) 治疗延迟的移植功能并没有增加感染风险或改善结果. 需要进一步的研究来平衡风险和收益.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 延迟移植功能 (DGF) 是移植后的一个常见并发症.
- 抗胸细胞球蛋白 (ATG) 用于DGF,但其在免疫风险较低的接受者中的安全性尚不清楚.
- ATG可能会增加感染风险,同时可能减少排斥.
研究的目的:
- 评估使用ATG治疗DGF的安全性和有效性,对免疫风险较低的移植接受者进行评估.
- 为了比较那些为DGF接受ATG和那些没有接受ATG的接受者之间的感染率,排斥率和移植结果.
主要方法:
- 139名已故捐赠移植受体的回顾性队列研究 (2019年6月至2023年6月).
- 与68名接受了DGF的ATG的受试者进行了比较,与71名仅接受巴西西马布诱导的对照者进行了比较.
- 结果包括BK病毒,CMV,严重感染,急性排斥,移植损失和死亡.
主要成果:
- 接受ATG的患者年龄较大,接受的高风险捐赠脏更多.
- 两组之间BK,CMV或严重感染率没有显著差异.
- 观察到类似的急性排斥,移植损失和死亡率.
结论:
- 在低免疫风险的移植接受者中使用ATG对DGF并没有显著增加感染风险.
- 在这个人群中,ATG并没有改善移植结果.
- 在低风险受益者中,ATG对DGF的风险效益概况需要进一步调查.
相关概念视频
01:40Cell-mediated Immune Responses
Overview
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...